M&A


  • Patient's view of dentist holding two dental instruments.
    Image attribution tooltip
    Peter Macdiarmid via Getty Images
    Image attribution tooltip

    Steris to sell dental segment for $787.5M

    Divesting the business will allow Steris to repay debt and focus on its core markets of healthcare, pharma and medtech.

    By April 11, 2024
  • Image attribution tooltip
    Mario Tama via Getty Images
    Image attribution tooltip

    J&J to acquire Shockwave Medical for $13.1B

    The deal comes just over a week after The Wall Street Journal reported that the companies were discussing a merger.

    By Updated April 5, 2024
  • A staff member from McSwain Union Elementary School District in Merced, California participates in the district's voluntary COVID-19 testing pilot. Explore the Trendline
    Image attribution tooltip
    Permission granted by Roy Mendiola
    Image attribution tooltip
    Trendline

    MedTech Dive Outlook 2022

    The pandemic continues to disrupt the medical device industry early in 2022, as COVID-19 testing demand remains strong and nonemergent procedures are postponed. In this series, we look at the risks, challenges and opportunities ahead.

    By MedTech Dive staff
  • Birds-eye view of the Exonics headquarters building
    Image attribution tooltip
    Retrieved from Axonics on August 22, 2023
    Image attribution tooltip

    FTC asks Boston Scientific for more info on $3.7B Axonics deal

    The company has pushed back its expected closing date for the acquisition due to the second request from the Federal Trade Commission.

    By April 4, 2024
  • 3M headquarters in Minnesota
    Image attribution tooltip

    Courtesy of 3M.

    Image attribution tooltip

    3M spins out Solventum

    The new company will need to work through debt from the spinoff and sole-source arrangements with 3M.

    By April 1, 2024
  • A picture of the exterior of a Labcorp building.
    Image attribution tooltip
    Courtesy of Labcorp
    Image attribution tooltip

    Labcorp inks $237.5M buyout of Opko’s reproductive, women’s health testing assets

    The acquired assets generate about $100 million in annual revenue, according to the deal announcement.

    By March 29, 2024
  • Photo of Michael F. Mahoney, CEO of Boston Scientific.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip

    Boston Scientific’s $3.7B Axonics buy tops list of medtech M&A in 2024

    Medtech dealmaking has not yet taken off this year, but there have been a number of smaller tuck-in acquisitions and private equity agreements.

    By March 28, 2024
  • A sign with company logo in red on a white background at the entrance to Johnson & JOhnson medical device unit
    Image attribution tooltip
    Mario Tama/Getty via Getty Images
    Image attribution tooltip

    J&J in talks to buy Shockwave Medical: WSJ

    The healthcare giant could follow up its $16.6 billion acquisition of Abiomed with another deal for a heart device company, the WSJ reported Tuesday.

    By March 27, 2024
  • A cylindrical device made of braided metal
    Image attribution tooltip
    AlexeyKamenskiy via Getty Images
    Image attribution tooltip

    Johnson Matthey to sell medical device components unit for $700M

    The segment makes components for medical devices, such as nitinol and metallic coatings.

    By March 20, 2024
  • Technicians using a titan medical robotic surgery device.
    Image attribution tooltip
    Retrieved from Titan on September 12, 2022
    Image attribution tooltip

    Titan Medical to merge with imaging firm Conavi, ending strategic review

    The combined company will focus on selling Conavi’s cardiovascular imaging system used in minimally invasive procedures.

    By March 19, 2024
  • An image of Attune Medical's ensoETM device.
    Image attribution tooltip
    Permission granted by Attune Medical
    Image attribution tooltip

    Haemonetics to buy Attune Medical for $160M

    Attune’s device to help cool the esophagus during radiofrequency ablation procedures is a key piece of the acquisition.

    By March 5, 2024
  • A windowed building surrounded by trees with a sign "Baxter" in front
    Image attribution tooltip
    Tim Boyle via Getty Images
    Image attribution tooltip

    Baxter considers selling kidney care unit to private equity

    The company expects to divest its largest segment, whether through a spinoff or a sale, in the second half of the year.

    By March 4, 2024
  • The concept of the word M&A on cubes on a beautiful green background. Business concept
    Image attribution tooltip
    Zhanna Hapanovich via Getty Images
    Image attribution tooltip

    Agiliti to go private in $2.5B PE deal

    After the transaction’s expected close in the first half of this year, Agiliti will no longer trade on the New York Stock Exchange.

    By Feb. 26, 2024
  • A judge's gavel is shown sitting idle on a thick, cherry stained, perhaps mahogany desk. The judge's hands are visible but out of focus in the background.
    Image attribution tooltip
    Kuzma via Getty Images
    Image attribution tooltip

    Ex-Mazor exec convicted of insider trading conspiracy linked to $1.6B Medtronic deal

    A federal jury found Doron Tavlin guilty on one count of conspiracy to commit insider trading and 10 counts related to securities fraud.

    By Feb. 22, 2024
  • An empty hospital operating theater is prepared with lighting and equipment
    Image attribution tooltip
    JohnnyGreig via Getty Images
    Image attribution tooltip

    The top medtech trends in 2024

    Experts said M&A, orthopedic procedure backlogs and emerging cardiac markets were among the top trends to watch in the medical device industry this year.

    By MedTech Dive Staff • Jan. 31, 2024
  • Exterior view of a building with columns and a sign that says "Cook."
    Image attribution tooltip
    Courtesy of Cook Medical
    Image attribution tooltip

    Cook Medical sells ear, nose and throat devices to C2Dx

    The transaction completes Cook’s divestiture of its otolaryngology, head and neck surgery product lines.

    By Jan. 26, 2024
  • Blocks spell M and A
    Image attribution tooltip
    Nastassia Samal via Getty Images
    Image attribution tooltip

    Invitae sells reproductive health assets amid liquidity concerns

    DNA testing firm Natera could pay up to $52.5 million total, and plans to move Invitae’s customers to its own tests.

    By Jan. 22, 2024
  • Two wooden blocks on a computer keyboard that spell out "M&A"
    Image attribution tooltip
    Maks_Lab via Getty Images
    Image attribution tooltip

    Integer acquires Pulse Technologies for $140M

    Pulse specializes in the micro machining of components for medical devices used in markets such as structural heart.

    By Jan. 16, 2024
  • Photo of Michael F. Mahoney, CEO of Boston Scientific.
    Image attribution tooltip
    Courtesy of Boston Scientific
    Image attribution tooltip
    Deep Dive

    5 medtech trends to watch in 2024

    From the M&A outlook and tough year-over-year comparisons to emerging markets like pulsed field ablation, here are the top medical technology trends to watch this year.

    By Jan. 9, 2024
  • Birds-eye view of the Exonics headquarters building
    Image attribution tooltip
    Retrieved from Axonics on August 22, 2023
    Image attribution tooltip

    Boston Scientific to buy Axonics for $3.7B to gain incontinence treatment

    The acquisition provides a high-growth addition to Boston Scientific’s urology business, analysts said.

    By Jan. 8, 2024
  • Sunny Kumar
    Image attribution tooltip
    Permission granted by GSR Ventures
    Image attribution tooltip
    Q&A

    ‘Healthy pullback’: GSR Ventures’ Sunny Kumar on normalizing digital health funding, accelerating M&A in 2024

    Sunny Kumar discusses digital healthcare investment, the landscape for M&A and when the public markets could open back up. 

    By Emily Olsen • Jan. 8, 2024
  • A Roche logo is seen on the side of a building.
    Image attribution tooltip
    Courtesy of Roche
    Image attribution tooltip

    Roche to buy LumiraDx’s point-of-care technology for $295M

    LumiraDx faces financial pressures amid declining test sales and a potential delisting from the Nasdaq.

    By Jan. 2, 2024
  • A person wearing safety goggles holds a pipette of fluid.
    Image attribution tooltip
    Courtesy of Grail
    Image attribution tooltip

    Roundup: Illumina’s long goodbye to cancer test maker Grail

    From the start, the DNA sequencing leader faced pressure to unwind its $8 billion acquisition of the cancer screening developer. As 2023 drew to a close, it has finally agreed.

    By Dec. 21, 2023
  • An x-ray image of a person's pelvis shows a hip replacement on the left side.
    Image attribution tooltip
    ChooChin via Getty Images
    Image attribution tooltip

    Stryker buys joint replacement business Serf Sas

    The purchase is expected to complement Stryker’s business in Europe and its joint replacement portfolio.

    By Dec. 20, 2023
  • Thermo Fisher Scientific
    Image attribution tooltip
    Courtesy of Thermo Fisher Scientific
    Image attribution tooltip

    Roundup: Medtech M&A slump continues but analysts predict uptick in 2024

    Globus Medical and Thermo Fisher were among the companies to announce billion dollar deals this year, while Medtronic and Boston Scientific called off acquisitions.

    By Dec. 19, 2023
  • The entrance to Illumina's San Diego campus.
    Image attribution tooltip
    Courtesy of Illumina
    Image attribution tooltip

    Illumina to part with Grail, ending battle with regulators

    Activist investor Carl Icahn, who is suing the company over its acquisition of Grail, continued to push for the removal of several board members in a letter to fellow shareholders.

    By Dec. 18, 2023